Lab21 acquires Biotec Laboratories

Cambridge technology firm Lab21 has acquired Biotec Laboratories, an Ipswich-based clinical diagnostic company. The terms of the deal remain undisclosed. 


Cambridge technology firm Lab21 has acquired Biotec Laboratories, an Ipswich-based clinical diagnostic company. The terms of the deal remain undisclosed. 

Cambridge technology firm Lab21 has acquired Biotec Laboratories, an Ipswich-based clinical diagnostic company. The terms of the deal remain undisclosed.

As part of the sale, Lab21 has also acquires Biotec’s South African subsidiary, Biotec Laboratories SA, which is a joint venture with the Cape Biotech Trust. The deal is in line with Lab21’s strategy to enter new markets and expand its global reach.

Lab21 CEO Graham Mullis said: “Our goal is to grow Lab21 into a major international diagnostics business through both organic growth and acquisition – this transaction is an important step in that process. Our combined businesses, which have very complementary products, provide a great platform from which to build further our infectious disease and immunodiagnostic portfolio.” 

Nick Britton

Lexus Ernser

Nick was the Managing Editor for growthbusiness.co.uk when it was owned by Vitesse Media, before moving on to become Head of Investment Group and Editor at What Investment and thence to Head of Intermediary...

Related Topics

Venture capital funding